Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy – Authors' Reply
The Lancet - United Kingdom
doi 10.1016/s0140-6736(19)32605-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2019
Authors
Publisher
Elsevier BV